Conditions: Acquired Fibrinogen Deficiency
Interventions: Biological: CSL511 Fibrinogen concentrate (human); Biological: Cryoprecipitate
Sponsors: CSL Behring
Not yet recruiting
Feeds
32933 items (32933 unread) in 74 feeds
Acinar Cell Carcinoma
(534 unread)
Acinic Cell Carcinoma
(314 unread)
Adenoid Cystic Carcinoma
(566 unread)
Adrenal Gland Cancer
(2429 unread)
Ampulla Of Vater
(469 unread)
Anal Cancer
(2709 unread)
Angiosarcoma
(990 unread)
Appendix Cancer
(684 unread)
Bile Duct Cancer
(4355 unread)
Brain and CNS
(6120 unread)
Carcinoid
(887 unread)
Endocrine/Neuroendocrine
(5825 unread)
Gall Bladder Cancer
(1132 unread)
Hemangioendothelioma
(1176 unread)
Hepatoblastoma
(770 unread)
Pancreas
(563 unread)
Phyllodes
(384 unread)
PMP and Mucinous Tumors
(477 unread)
Rhabdomyosarcoma
(1118 unread)
Sarcoma
(1431 unread)
Trial - Pseudomyxoma Peritonei (11 unread)
-
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
Posted: September 30th, 2024, 11:00pm UTC
-
Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
Posted: July 22nd, 2024, 11:00pm UTC
Conditions: Pseudomyxoma Peritonei
Interventions: Drug: Mitomycin c
Sponsors: University of Southampton
Not yet recruiting -
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
Posted: October 16th, 2023, 11:00pm UTC
Conditions: Secondary Malignant Neoplasm of Retroperitoneum; Secondary Malignant Neoplasm of Peritoneum; Pseudomyxoma Peritonei
Interventions: Procedure: Intestinal, Multivisceral or Modified Multivisceral Transplantation; Drug: Alemtuzumab; Drug: Tacrolimus; Drug: Sirolimus
Sponsors: Case Comprehensive Cancer Center
Not yet recruiting -
Gastrointestinal Stimulation as a Treatment of Postoperative Ileus Following Extensive Surgery
Posted: March 2nd, 2023, 1:00am UTC
Conditions: Postoperative Ileus; Bowel Paralysis
Interventions: Device: Gastric electric pacemaker
Sponsors: University of Aarhus; Danish Cancer Society
Recruiting -
Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy
Posted: March 31st, 2022, 11:00pm UTC
Conditions: Peritoneal Malignancy; Ovarian Cancer; Rectum Cancer; Appendix Cancer; Colon Cancer
Interventions: Behavioral: Exercise; Behavioral: Nutrition
Sponsors: Dublin City University; Mater Misericordiae University Hospital; Royal College of Surgeons, Ireland
Active, not recruiting -
Flat Dose Vs. Weight-based IP Chemotherapy for CRS/HIPEC
Posted: March 3rd, 2021, 1:00am UTC
Conditions: Peritoneal Carcinomatosis
Interventions: Drug: Mitomycin C, flat dose 40 mg; Drug: Mitomycin C, weight-based dose 12.5 mg/m2
Sponsors: Prakash Pandalai
Recruiting -
A Study of SGN-STNV in Advanced Solid Tumors
Posted: December 14th, 2020, 1:00am UTC
Conditions: Carcinoma, Non-Small Cell Lung; HER2 Negative Breast Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Carcinoma; Stomach Neoplasms; Colorectal Neoplasms; Exocrine Pancreatic Adenocarcinoma; Appendiceal Adenocarcinoma; Pseudomyxoma Peritonei
Interventions: Drug: SGN-STNV
Sponsors: Seagen Inc.
Terminated -
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Posted: July 18th, 2019, 11:00pm UTC
Conditions: Peritoneal Carcinomatosis; Pseudomyxoma Peritonei; Mesothelioma Peritoneum
Interventions: Other: Cardiac coherence; Other: Standard care
Sponsors: Institut du Cancer de Montpellier - Val d'Aurelle
Recruiting -
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Posted: July 15th, 2016, 11:00pm UTC
Conditions: Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortical Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Breast Metaplastic Carcinoma; Cervical Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Neuroendocrine Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Solid Neoplasm; Malignant Testicular Sex Cord-Stromal Tumor; Metastatic Malignant Neoplasm of Unknown Primary; Metastatic Pituitary Neuroendocrine Tumor; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Low Grade Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Penile Squamous Cell Carcinoma; Peritoneal Mesothelial Neoplasm; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Spindle Cell Neoplasm; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab
Sponsors: National Cancer Institute (NCI)
Active, not recruiting -
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Posted: September 20th, 2013, 11:00pm UTC
Conditions: Gastrointestinal Neoplasms
Interventions: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting -
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Posted: June 12th, 2012, 11:00pm UTC
Conditions: Peritoneal Carcinomatosis; Pseudomyxoma Peritonei; Peritoneal Mesothelioma
Sponsors: Universitaire Ziekenhuizen KU Leuven
Recruiting